ArticleJAMA network open2023

Assessment of Tyrosine Kinase Inhibitors and Survival and Cardiovascular Outcomes of Patients With Non-Small Cell Lung Cancer in Taiwan.

Wei-Ting Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.